Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
There is currently no usage information available for this product. We apologize for any inconvenience.
There is currently no drug history available for this drug.
INNOPRAX-5® is comprised of 8 g of Amantadine HCl USP and 6 g of Gabapentin USP, 3 g of Diclofenac Sodium USP, 3 g of Baclofen USP, and 5 g of Lidocaine HCl USP for topical use.1 INNOPRAX-5® also contains a Cream Base containing purified water, white petrolatum, sorbitol solution, cetearyl alcohol, propylene glycol, ceteareth-20, simethicone, glyceryl monostearate, polyethylene glycol monostearate, sorbic acid and BHT. When mixed as instructed, the final product provides a homogeneous cream mixture containing Amantadine HCl, Gabapentin, Diclofenac Sodium, Baclofen, and Lidocaine HCl comparable to the active ingredients (Symmetrel®, Neurontin®, Voltaren Gel®, Lioresal® and Xylocaine®) contained in INNOPRAX-5®.
- Certificate of analysis on file
- This product is not manufactured by BMS Pharma. Co, manufacturer of Symmetrel ®, or by Pfizer Inc., manufacturer of Neurontin, or by Novartis Pharmaceuticals Corp., manufacturer of Voltaren Gel and Lioresal®, or by AstraZeneca LP, manufacturer of Xylocaine®.